Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine and Inactivated Influenza Vaccine in Adults
Authors:
- Daniel F. HoftDHDaniel F. Hoft
- Kathleen R. LottenbachKLKathleen R. Lottenbach
- Azra BlazevicABAzra Blazevic
- Aldin TuranATAldin Turan
- Tamara P. BlevinsTBTamara P. Blevins
- Thomas P. PacatteTPThomas P. Pacatte
- Yinyi YuYYYinyi Yu
- Michelle C. MitchellMMMichelle C. Mitchell
- Stella G. HoftSHStella G. Hoft
- Robert B. BelsheRBRobert B. Belshe
- 1 January 2017
- journal article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 24 (1)
Abstract
Both live attenuated influenza vaccines (LAIV) and inactivated influenza vaccines (IIV) induce protective immunity against influenza. There is evidence that LAIV induces superior protection in children, whereas IIV may induce superior protection in adults. The immune mechanisms responsible for these differences have not been identified. We previously compared LAIV and IIV in young children of 6 to 36 months of age, and we demonstrated that while both induced similar hemagglutination inhibition (HAI) antibody responses, only LAIV induced significant increases in T cell responses. In the present study, 37 healthy adult subjects of 18 to 49 years of age were randomized to receive seasonal influenza vaccination with LAIV or IIV. Influenza virus-specific HAI, T cell, and secretory IgA (sIgA) responses were studied pre- and postvaccination. In contrast to the responses seen in young children, LAIV induced only minimal increases in serum HAI responses in adults, which were significantly lower than the responses induced by IIV. Both LAIV and IIV similarly induced only transient T cell responses to replication-competent whole virus in adults. In contrast, influenza virus-specific sIgA responses were induced more strongly by LAIV than by IIV. Our previous studies suggest that LAIV may be more protective than IIV in young children not previously exposed to influenza virus or influenza vaccines due to increased vaccine-induced T cell and/or sIgA responses. Our current work suggests that in adults with extensive and partially cross-reactive preexisting influenza immunity, LAIV boosting of sIgA responses to hemagglutinin (HA) and non-HA antigenic targets expressed by circulating influenza virus strains may be an important additional mechanism of vaccine-induced immunity.Keywords
Funding Information
- MedImmune Investigator-Initiated Award (AGR-404680)
This publication has 28 references indexed in Scilit:
- Live and Inactivated Influenza Vaccines Induce Similar Humoral Responses, but Only Live Vaccines Induce Diverse T-Cell Responses in Young ChildrenThe Journal of Infectious Diseases, 2011
- The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adultsInfluenza and Other Respiratory Viruses, 2010
- Comparative Efficacy of Inactivated and Live Attenuated Influenza VaccinesNew England Journal of Medicine, 2009
- Influence of Prior Influenza Vaccination on Antibody and B-Cell ResponsesPLOS ONE, 2008
- Prevention of Symptomatic Seasonal Influenza in 2005–2006 by Inactivated and Live Attenuated VaccinesThe Journal of Infectious Diseases, 2008
- Baseline Levels of Influenza-Specific CD4 Memory T-Cells Affect T-Cell Responses to Influenza VaccinesPLOS ONE, 2008
- The Chemokine Receptor CCR5 Plays a Key Role in the Early Memory CD8+ T Cell Response to Respiratory Virus InfectionsImmunity, 2008
- Comparison of the Influenza Virus-Specific Effector and Memory B-Cell Responses to Immunization of Children and Adults with Live Attenuated or Inactivated Influenza Virus VaccinesJournal of Virology, 2007
- Prevention of Antigenically Drifted Influenza by Inactivated and Live Attenuated VaccinesNew England Journal of Medicine, 2006
- Cellular Immune Responses in Children and Adults Receiving Inactivated or Live Attenuated Influenza VaccinesJournal of Virology, 2006